FDA

The False Promise of Animal Testing: Safety and Efficacy

One fact that was drilled into my head while studying biomedical science was how few experimental drugs ever make it past clinical trials. A failure rate of 90% is reported. This struck me as odd, but I chalked it up as an example of how difficult drug development is and didn't ask why. That changed

Double Take of Ban the Bottle: FOR

This piece is part of a “Double Take”, where two parties argue on either side of a premise. A writer does not necessarily share the view they are arguing; instead, this is an exercise to fully flesh out a discussion.  The premise: “Single-serve, plastic water bottles should be banned in the United States.” I am

Right To Try, A Legislative Placebo

On May 30th President Trump signed the “Right to Try Act” into law. This legislation lets terminally ill patients try experimental medications that have completed Phase 1 clinical trial testing but have not yet been approved by the Food and Drug Administration (FDA). On the surface, this legislation seems like a victory for patients without

Scroll to Top